FNY Investment Advisers’s Viking Therapeutics VKTX Stock Holding History

FNY Investment Advisers’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6K	Buy	164 +102	+165%	+$3.29K	﹤0.01%	668
2026 Q1	$2K	Buy	62 +21	+51%	+$675	﹤0.01%	679
2025 Q4	$1K	Buy	+41	New	+$1.45K	﹤0.01%	864
2025 Q3	–	Sell	-108	Closed	-$2K	–	1545
2025 Q2	$2K	Buy	+108	New	+$2.84K	﹤0.01%	869
2025 Q1	–	Sell	-35	Closed	-$1K	–	1004
2024 Q4	$1K	Buy	+35	New	+$2K	﹤0.01%	642
2024 Q3	–	Sell	-299	Closed	-$15K	–	833
2024 Q2	$15K	Buy	299 +158	+112%	+$10.4K	0.01%	326
2024 Q1	$11	Buy	+141	New	+$6.27K	0.01%	450
2019 Q3	–	Sell	-208	Closed	-$1K	–	1188
2019 Q2	$1K	Sell	208 -322	-61%	-$2.75K	﹤0.01%	907
2019 Q1	$5K	Buy	+530	New	+$4.44K	﹤0.01%	517

Other funds holding VKTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

FNY Investment Advisers's VKTX Position: Q2 2026 in Review

FNY Investment Advisers reduced its Viking Therapeutics (VKTX) stake by 10% in Q2 2026, selling an estimated $30.2K and leaving 8,170 shares worth $318K. The position accounts for 0.11% of the portfolio, ranked #195.

FNY Investment Advisers first reported a position in VKTX in Q2 2018 and has held it in 29 quarters since. The position peaked at $758K in Q3 2024. 207 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

FNY Investment Advisers held 8,170 shares of Viking Therapeutics worth $318K as of Q2 2026.
FNY Investment Advisers sold 934 Viking Therapeutics shares in Q2 2026, an estimated $30.2K.
Viking Therapeutics made up 0.11% of FNY Investment Advisers's portfolio in Q2 2026, its #195 holding.
FNY Investment Advisers first reported a position in Viking Therapeutics in Q2 2018 and has held it in 29 quarters since.
FNY Investment Advisers's Viking Therapeutics position peaked at $758K in Q3 2024.
207 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.